EU experts add new warnings to Glaxo's Avandia
445463
European regulators on Thursday recommended that patients with heart disease or leg pains -- a possible sign of heart problems -- should not take GlaxoSmithKline's diabetes drug Avandia.
349354
All studies so far provide inconsistent results about the potential heart risks of GlaxoSmithKline Plc's diabetes drug Avandia, the head of the Food and Drug Administration told lawmakers on Wednesday.
146979
An independent analysis of thousands of older people with diabetes found that those treated with the widely used drug Avandia had significantly elevated risks of heart attack and death.
502254
The European Medicines Agency has  recommended conditional approval of GlaxoSmithKline Plc's new  breast cancer pill Tykerb, Europe's biggest drugmaker said on  Friday.
695544
GlaxoSmithKline is expected to be hit with a wave of lawsuits from users of the diabetes drug Avandia, plaintiff's lawyers said on Wednesday.
761256
The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress...
646
The European Union is warned to take steps to combat the growing problem of counterfeit drugs.
51255
The diabetes drug Actos cuts the risk of heart attack, stroke and death, but raises the risk of heart failure, according to one study published on Tuesday, while a second confirmed disputed findings that rival Avandia raises heart risks.
238078
Pfizer Inc.'s painkiller Bextra will come with a new warning about the possibility of heart attacks and blood clots in patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
147580
Glaxo expects that the impact of lower sales of its diabetes drug, Avandia, will help cause a drop of about 5 percent in earnings a share in 2008.
542334
Galvus, a diabetes drug produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety issues.
186503
The government and Genentech are warning doctors that Avastin, which is used to treat colorectal cancer, increases patients' risk of potentially lethal heart ailments.
667330
Business & money: Europe's largest drugmaker blames safety concerns over its Avandia diabetes pill
312552
Galvus, a diabetes medicine produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety concerns.
508415
An early analysis from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show whether there was any increase in heart attacks among patients, but several experts said the evidence still suggested the popular diabetes drug raised the risk of heart attack.
565830
Early results from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show any increase in heart attacks among patients, but several experts said the evidence still suggests the popular diabetes drug raises the risk of heart attack.